#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15032	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2257	660.9	0	.	n	.	0	C1450T	SNP	1450	1450	C	1792	1792	T	837	T,C	790,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15032	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2257	660.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1526	1526	C	793	C	782	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28370	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3149	863.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1338	1338	A	982	A,G	951,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28370	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3149	863.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	1972	1972	C	843	C	818	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28370	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3149	863.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2046	2046	A	853	A	833	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28370	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3149	863.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2598	2598	C	817	C	796	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	27	30940	blaTEM	861	861	100.0	blaTEM.l6.c17.ctg.1	1596	1925.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2074	folP	855	855	99.88	folP.l15.c4.ctg.1	1627	126.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1122	1124	AGC	209;216;215	A;G;C	205;210;205	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	5850	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3392	171.3	0	.	p	.	0	D95A	NONSYN	283	285	GAC	637	639	GCC	187;186;185	G;C,T;C	184;183,1;181	.	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	5850	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3392	171.3	1	SNP	p	S91F	1	.	.	271	273	TTC	625	627	TTC	192;190;190	T;T,C;C	187;185,1;186	gyrA.WHO_G_01105:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	531	1668	mtrR	633	633	99.06	mtrR.l15.c30.ctg.1	1567	106.2	0	.	p	.	0	A39T	NONSYN	115	117	GCC	541	543	ACC	231;230;231	A,G;C;C	211,1;217;214	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	531	1668	mtrR	633	633	99.06	mtrR.l15.c30.ctg.1	1567	106.2	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	739	741	CAC	206;203;204	C;A;C	202;192;200	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	531	1668	mtrR	633	633	99.06	mtrR.l15.c30.ctg.1	1567	106.2	0	.	p	.	0	A127fs	FSHIFT	379	379	G	805	805	G	196	G,T	178,1	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	531	1668	mtrR	633	633	99.06	mtrR.l15.c30.ctg.1	1567	106.2	1	SNP	p	G45D	0	.	.	133	135	GGC	559	561	GGC	232;230;230	G;G;C	218;221;219	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	982	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1128	86.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5028	parC	2304	2304	99.7	parC.l15.c17.ctg.1	2843	175.6	0	.	p	.	0	S87N	NONSYN	259	261	AGT	505	507	AAT	163;162;164	A;A;T	162;160;162	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5028	parC	2304	2304	99.7	parC.l15.c17.ctg.1	2843	175.6	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1396	1398	GTC	211;212;214	G;T;C	203;199;207	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5028	parC	2304	2304	99.7	parC.l15.c17.ctg.1	2843	175.6	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1549	1551	GCA	219;218;220	G,T;C,A;A	214,1;207,1;201	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5028	parC	2304	2304	99.7	parC.l15.c17.ctg.1	2843	175.6	1	SNP	p	D86N	0	.	.	256	258	GAC	502	504	GAC	155;156;160	G;A;C,T	154;154;158,1	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5028	parC	2304	2304	99.7	parC.l15.c17.ctg.1	2843	175.6	1	SNP	p	S88P	0	.	.	262	264	TCC	508	510	TCC	167;169;168	T;C;C	164;165;165	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4278	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2590	163.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1495	1497	GGC	206;204;205	G;G,A;C	201;199,1;196	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.19.001	penA.19.001	1	1	27	3912	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2238	172.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1171	1173	GCA	229;227;228	G;C;A	217;215;221	penA.19.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3912	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2238	172.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1174	1176	ATC	227;225;227	A,T;T;C	221,1;217;218	penA.19.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3912	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2238	172.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1186	1188	GTG	224;223;222	G;T,G;G	220;213,1;216	penA.19.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3912	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2238	172.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1186	1188	GTG	224;223;222	G;T,G;G	220;213,1;216	penA.19.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3912	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2238	172.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1690	1692	ACC	195;194;195	A;C;C	187;186;190	penA.19.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3912	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2238	172.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1744	1746	GCG	214;209;210	G;C,G,A;G,A	203;183,2,1;203,1	penA.19.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3912	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2238	172.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1744	1746	GCG	214;209;210	G;C,G,A;G,A	203;183,2,1;203,1	penA.19.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3912	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2238	172.3	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1867	1869	GGT	143;140;144	G;G;T	141;139;141	penA.19.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3912	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2238	172.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1876	1878	GGC	147;144;141	G,T;G;C	144,1;141;138	penA.19.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3912	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2238	172.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1894	1896	CCG	129;131;126	C,G;C,G;G,C	110,4;114,1;110,2	penA.19.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6076	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	2965	203.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1539	1541	CCG	215;216;212	C,G;C;G	198,1;208;202	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2428	porA	1146	1146	99.65	porA.l6.c30.ctg.1	1879	128.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	530	530	C	173	C	159	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2910	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1609	179.2	0	.	p	.	0	R143G	NONSYN	427	429	AGA	735	737	GGA	230;227;225	G;G;A	222;218;213	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2910	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1609	179.2	0	.	p	.	0	.	INDELS	629	630	AA	938	940	TAG	235;236;230	T;A;G	226;230;215	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2910	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1609	179.2	0	.	p	.	0	.	MULTIPLE	631	633	TAC	942	945	CAAT	228;230;230;232	C;A;A;T	223;222;229;226	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2910	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1609	179.2	0	.	p	.	0	N212fs	FSHIFT	634	634	A	947	947	T	233	T	229	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2910	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1609	179.2	1	SNP	p	G120K	0	.	.	358	360	GGT	666	668	GGT	226;222;225	G,T;G;T	220,1;217;214	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2910	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1609	179.2	1	SNP	p	A121N	0	.	.	361	363	GCC	669	671	GCC	225;223;221	G;C;C,A	220;214;216,1	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2910	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1609	179.2	1	SNP	p	A121D	0	.	.	361	363	GCC	669	671	GCC	225;223;221	G;C;C,A	220;214;216,1	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	10724	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4875	218.4	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	1968	1970	AAT	244;246;248	A;A;T	241;241;242	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1254	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1067	116.8	1	SNP	p	V57M	1	.	.	169	171	ATG	532	534	ATG	235;234;237	A;T;G	228;225;227	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9920	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2753	358.4	0	.	p	.	0	M177T	NONSYN	529	531	ATG	885	887	ACG	410;402;399	A;C,T;G	401;393,1;390	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9920	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2753	358.4	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	906	908	GAC	388;383;383	G;A;C	386;375;380	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9920	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2753	358.4	0	.	p	.	0	T190M	NONSYN	568	570	ACG	924	926	ATG	381;381;381	A;T;G	380;381;381	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9920	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2753	358.4	0	.	p	.	0	L194S	NONSYN	580	582	TTA	936	938	TCA	393;387;391	T;C;A	392;386;386	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9920	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2753	358.4	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	981	983	CAG	395;391;387	C;A;G	393;387;383	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9920	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2753	358.4	0	.	p	.	0	V216L	NONSYN	646	648	GTT	1002	1004	CTT	359;355;350	C;T;T	357;353;347	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9920	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2753	358.4	0	.	p	.	0	N223S	NONSYN	667	669	AAC	1023	1025	AGT	337;339;346	A;G;T,A	330;331;329,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9920	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2753	358.4	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1092	1094	CCG	444;450;456	C,A;C;G	435,1;440;445	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9920	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2753	358.4	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1194	1196	TCG	460;462;464	T;C;G	448;447;451	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9920	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2753	358.4	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1365	1367	AAA	261;260;259	A;A;A	254;254;253	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9920	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2753	358.4	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1368	1370	AAG	260;256;255	A;A;G	253;249;249	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9920	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2753	358.4	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1383	1385	CAC	230;229;229	C;A;C	229;221;228	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9920	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2753	358.4	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1422	1424	GAA	233;234;238	G;A;A	233;232;238	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9920	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2753	358.4	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1500	1502	ACG	178;175;170	A;C;G	177;175;169	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9920	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2753	358.4	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1551	1553	ATT	233;233;239	A;T;T	229;231;236	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9920	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2753	358.4	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1554	1556	AGT	240;237;237	A;G;T	237;236;232	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9920	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2753	358.4	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1593	1595	CTA	259;262;265	C,A;T;A	255,1;257;261	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9920	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2753	358.4	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1635	1637	AAT	192;193;194	A;A;T	192;191;191	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9920	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2753	358.4	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1704	1706	TCA	259;262;267	T;C;A	257;258;260	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9920	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2753	358.4	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1728	1730	ATG	290;288;290	A;T;G	284;284;285	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9920	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2753	358.4	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	2022	2024	ACC	553;552;554	A;C;C,T	531;535;534,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9920	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2753	358.4	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2118	2120	GAA	525;527;527	G,T;A;A,T	513,2;518;516,1	.	Tetracycline resistance
